Seite wählen
Publications 2012
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy.
Fadini GP, Albiero M, Seeger F, Poncina N, Menegazzo L, Angelini A, Castellani C, Thiene G, Agostini C, Cappellari R, Boscaro E, Zeiher A, Dimmeler S, Avogaro A.
Basic research in cardiology 2012; 10812013Jan: 313
Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.
de Jager SC, Bongaerts BW, Weber M, Kraaijeveld AO, Rousch M, Dimmeler S, van Dieijen-Visser MP, Cleutjens KB, Nelemans PJ, van Berkel TJ, Biessen EA.
PloS one 2012; 792012: e45804
G-CSF-Stimulation And Coronary Reinfusion Of Mobilized Circulating Mononuclear Proangiogenic Cells In Patients With Chronic Ischemic Heart Disease: Five Year Results Of The TOPCARE- G-CSF Trial.
Honold J, Fischer-Rasokat U, Lehmann R, Leistner DM, Seeger FH, Schachinger V, Martin H, Dimmeler S, Zeiher AM, Assmus B.
Cell transplantation 2012
Atheroprotective mechanisms of shear stress-regulated microRNAs.
Boon RA, Hergenreider E, Dimmeler S.
Thrombosis and haemostasis 2012; 10842012Oct: 616-20
Elevated Levels of the Mediator of Catabolic Bone Remodeling RANKL in the Bone Marrow Environment Link Chronic Heart Failure with Osteoporosis.
Leistner DM, Seeger FH, Fischer A, Röxe T, Klotsche J, Iekushi K, Seeger T, Assmus B, Honold J, Karakas M, Badenhoop K, Frantz S, Dimmeler S, Zeiher AM.
Circulation. Heart failure 2012; 562012Nov1: 769-777
Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.
Reis M, Czupalla CJ, Ziegler N, Devraj K, Zinke J, Seidel S, Heck R, Thom S, Macas J, Bockamp E, Fruttiger M, Taketo MM, Dimmeler S, Plate KH, Liebner S.
The Journal of experimental medicine 2012; 20992012Aug27: 1611-27
Hypoxia-induced alternative splicing in endothelial cells.
Weigand JE, Boeckel JN, Gellert P, Dimmeler S.
PloS one 2012; 782012: e42697
Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair.
Seeger FH, Rasper T, Fischer A, Muhly-Reinholz M, Hergenreider E, Leistner DM, Sommer K, Manavski Y, Henschler R, Chavakis E, Assmus B, Zeiher AM, Dimmeler S.
Circulation research 2012; 11172012Sep14: 854-62
MicroRNAs and aneurysm formation.
Boon RA, Dimmeler S.
Trends in cardiovascular medicine 2012; 2162011Aug: 172-7
MicroRNAs and aneurysm formation.
Boon RA, Dimmeler S.
Trends in cardiovascular medicine 2012; 2162011Aug: 172-7
Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.
Frömel T, Jungblut B, Hu J, Trouvain C, Barbosa-Sicard E, Popp R, Liebner S, Dimmeler S, Hammock BD, Fleming I.
Proceedings of the National Academy of Sciences of the United States of America 2012; 109252012Jun19: 9995-10000
Endothelial cell-specific FGD5 involvement in vascular pruning defines neovessel fate in mice.
Cheng C, Haasdijk R, Tempel D, van de Kamp EH, Herpers R, Bos F, Den Dekker WK, Blonden LA, de Jong R, Bürgisser PE, Chrifi I, Biessen EA, Dimmeler S, Schulte-Merker S, Duckers HJ.
Circulation 2012; 125252012Jun26: 3142-58
Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.
Xu Q, Seeger FH, Castillo J, Iekushi K, Boon RA, Farcas R, Manavski Y, Li YG, Assmus B, Zeiher AM, Dimmeler S.
Journal of the American College of Cardiology 2012; 59232012Jun5: 2107-17
Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells.
Prokoph S, Chavakis E, Levental KR, Zieris A, Freudenberg U, Dimmeler S, Werner C.
Biomaterials 2012; 33192012Jun: 4792-800
MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment.
Heinrich EM, Dimmeler S.
Circulation research 2012; 11072012Mar30: 1014-22
Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.
Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, Brandes RP.
Circulation research 2012; 11092012Apr27: 1217-25
Regenerative treatment of advanced heart disease.
Leistner DM, Seeger FH, Dimmeler S, Zeiher AM, Assmus B.
Deutsche medizinische Wochenschrift (1946) 2012; 137142012Apr: 732-7
Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction.
Iekushi K, Seeger F, Assmus B, Zeiher AM, Dimmeler S.
Circulation 2012; 125142012Apr10: 1765-73, S1-7
Pressure overload leads to an increase of cardiac resident stem cells.
Rupp S, Bauer J, von Gerlach S, Fichtlscherer S, Zeiher AM, Dimmeler S, Schranz D.
Basic research in cardiology 2012; 10722012Mar: 252
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.
Fadini GP, Losordo D, Dimmeler S.
Circulation research 2012; 11042012Feb17: 624-37
Intracoronary bone marrow cell application for terminal heart failure in children.
Rupp S, Jux C, Bönig H, Bauer J, Tonn T, Seifried E, Dimmeler S, Zeiher AM, Schranz D.
Cardiology in the young 2012; 2252012Oct: 558-63
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.
Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S.
Nature cell biology 2012; 1432012Mar: 249-56
MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A.
Urbich C, Kaluza D, Frömel T, Knau A, Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN, Hergenreider E, Zeiher AM, Kroll J, Fleming I, Dimmeler S.
Blood 2012; 11962012Feb9: 1607-16
Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow.
Assmus B, Iwasaki M, Schächinger V, Roexe T, Koyanagi M, Iekushi K, Xu Q, Tonn T, Seifried E, Liebner S, Kranert WT, Grünwald F, Dimmeler S, Zeiher AM.
European heart journal 2012; 33152012Aug: 1911-9